The goal of this research is to use synchronized (G0/G1) human T-lymphocytes as a model system to determine the critical molecular events that regulate cell growth. We will use molecular genetic approaches to identify the ordered, sequential expression of genes and gene products that occurs during cell cycle progression. Particular emphasis will be placed upon cellular oncogene expression after activation of the T-cell antigen receptor complex vs. interleukin 2 receptors. Hybridization subtraction approaches will be used to clone previously unrecognized genes. The structure, cellular location and functional relevance of gene products will be determined using antibodies reactive with synthetic peptides and recombinant proteins. In addition, studies will be initiated to identify the relevance of other peptide hormones, especially insulin and insulin-like growth factors, that may function to facilitate movement through the cell cycle. The mechanism by which interleukin 2 influences the expression of high and low affinity interleukin 2 receptors, thereby regulating the potential responsiveness of proliferating T-cells, will be approached using IL-2 receptor cDNA transfectants and by studies of IL-2 receptor mRNA expression. The unique cellular and molecular reagents that will be applied to these studies, combined with our current knowledge of the determinants of T-cell cycle progression, promise to provide a model for cell growth that cannot be paralleled in existing eukaryotic cell culture systems. Consequently, forthcoming information should have immediate relevance, not only to the regulation of the T-cell immune response, but also to cell growth in general.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA017643-15
Application #
3164767
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1979-01-01
Project End
1991-04-30
Budget Start
1990-04-01
Budget End
1991-04-30
Support Year
15
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Beadling, C; Johnson, K W; Smith, K A (1993) Isolation of interleukin 2-induced immediate-early genes. Proc Natl Acad Sci U S A 90:2719-23
Landgraf, B E; Goldstein, B; Williams, D P et al. (1992) Recombinant interleukin-2 analogs. Dynamic probes for receptor structure. J Biol Chem 267:18511-9
Zmuidzinas, A; Mamon, H J; Roberts, T M et al. (1991) Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells. Mol Cell Biol 11:2794-803
Landgraf, B E; Williams, D P; Murphy, J R et al. (1991) Conformational perturbation of interleukin-2: a strategy for the design of cytokine analogs. Proteins 9:207-16
Ehlers, S; Smith, K A (1991) Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 173:25-36
Caligiuri, M A; Zmuidzinas, A; Manley, T J et al. (1990) Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 171:1509-26
Landgraf, B; Cohen, F E; Smith, K A et al. (1989) Structural significance of the C-terminal amphiphilic helix of interleukin-2. J Biol Chem 264:816-22
Smith, K A (1988) Interleukin-2: inception, impact, and implications. Science 240:1169-76
Smith, K A (1988) The interleukin 2 receptor. Adv Immunol 42:165-79
Wang, H M; Smith, K A (1987) The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med 166:1055-69

Showing the most recent 10 out of 18 publications